Respiratory, Cold and Cough Range: Third Party Manufacturing
61 cough, cold, allergy, asthma and bronchodilator products, manufactured as syrups, drops, suspensions, tablets and capsules under your brand at our WHO-GMP plant in Panchkula.
Home›Products›Respiratory, cold and cough range
Respiratory medicines are a 19,000 crore rupee therapy in India, and the cough, cold and allergy products in it sell most between October and February, when the season and the air quality turn. Our catalogue carries 61 products in this range: 44 cough, cold and allergy products and 17 asthma and bronchodilator products, made in the oral liquid, tablet and capsule sections at Panchkula, with the syrups and drops filled on the plant’s own liquid line.
- Why this range. The market figures, the season and the 2025 syrup crisis that make the manufacturer behind a cough syrup the buyer’s first question.
- Why this plant for it. 61 products already on the licence, 26 packs manufactured for clients, a liquid section with 30 million bottles a year of capacity and a laboratory that tests for diethylene glycol at raw material, bulk and finished product stage.
- The full catalogue. Every product with composition, form and pack sizes.
7.9%of India’s medicine market is respiratory therapy, 19,043 crore rupees a year (Pharmarack, MAT January 2026)
66%rise in respiratory medicine sales from June to November 2024, the seasonal swing every year (Pharmarack)
61respiratory, cold and cough products on our licence
26packs in this range manufactured for our clients
Respiratory, cold and cough packs manufactured for our clients
Each pack carries the client’s brand and our name as manufacturer.
Ambroxol Hydrochloride, Levosalbutamol Sulphate, Guaiphenesin Syrup
Cetirizine Tablets IP 10mg
Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Dispersible Tablets
Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup
Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup
Diphenhydramine Hydrochloride, Ammonium Chloride and Sodium Citrate Syrup
Fexofenadine Tablets IP 120mg
Fexofenadine Tablets IP 180mg
Hydroxyzine Hydrochloride Oral Solution IP
Hydroxyzine Tablets IP 10mg
Hydroxyzine Tablets IP 25mg
Levosalbutamol, Ambroxol Hydrochloride and Guaiphenesin Syrup
Paracetamol and Caffeine Tablets IP
Paracetamol, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Oral Drops
Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesin and Menthol Syrup
Acebrophylline and N-Acetylcysteine Tablets
Acebrophylline Capsules 100mg
Acebrophylline Sustained Release Tablets 200mg
Acebrophylline, Guaiphenesin and Terbutaline Sulphate Syrup
Desloratadine and Montelukast Tablets
Doxofylline (SR) and Montelukast Tablets
Doxofylline Tablets IP 400mg
Montelukast and Fexofenadine Hydrochloride Tablets
Montelukast and Levocetirizine Syrup
Montelukast and Levocetirizine Tablets IP
Montelukast Sodium, Levocetirizine Dihydrochloride and Ambroxol Hydrochloride (SR) TabletsA starter range of 20 products
A first respiratory range that covers wet cough, dry cough, cold and fever, allergy, allergic rhinitis with asthma and bronchodilation, for adults and children, all from the catalogue
| Need | Products |
|---|---|
| Wet cough | Terbutaline 1.25 mg + Bromhexine 4 mg + Guaiphenesin 50 mg + Menthol syrup; Terbutaline 2.5 mg + Bromhexine 8 mg + Guaiphenesin 100 mg tablets; Levosalbutamol 1 mg + Ambroxol 30 mg + Guaiphenesin 50 mg syrup; Ambroxol 15 mg + Terbutaline 1.25 mg + Guaiphenesin 50 mg + Menthol syrup |
| Dry cough | Dextromethorphan 10 mg + Chlorpheniramine 4 mg syrup; Dextromethorphan 10 mg + Phenylephrine 5 mg + Chlorpheniramine 2 mg syrup |
| Cold and fever | Paracetamol 500 mg + Phenylephrine 10 mg + Chlorpheniramine 2 mg tablets; Paracetamol 125 mg + Phenylephrine 2.5 mg + Chlorpheniramine 1 mg drops; Phenylephrine 5 mg + Chlorpheniramine 2 mg syrup |
| Allergy | Levocetirizine 5 mg tablets; Levocetirizine 2.5 mg per 5 ml syrup; Cetirizine 10 mg tablets; Fexofenadine 120 mg tablets; Bilastine 20 mg tablets |
| Allergic rhinitis with asthma | Montelukast 10 mg + Levocetirizine 5 mg tablets; Montelukast 4 mg + Levocetirizine 2.5 mg syrup; Montelukast 10 mg + Fexofenadine 120 mg tablets |
| Bronchodilation and COPD | Doxofylline 400 mg tablets; Acebrophylline 100 mg capsules; Acebrophylline 100 mg + Acetylcysteine 600 mg tablets |
Send this list, or your own, with pack sizes and annual quantity, and the written proposal comes back product by product.
Why manufacture the range at this plant
What a marketing company gets from Vibcare Healthcare for a respiratory, cold and cough range
The molecules are already on the licence
All 61 products in the catalogue, including bilastine, montelukast with fexofenadine, doxofylline with montelukast and acebrophylline with acetylcysteine, are on the plant’s manufacturing licence. There is no wait for a state endorsement before the first batch.
Diethylene glycol tested at three stages, in-house
Glycerine, propylene glycol and sorbitol are the solvents in which diethylene glycol contamination has occurred. The plant tests for diethylene glycol and ethylene glycol on its own Agilent gas chromatograph at three stages: every container of solvent before it is released to production, the bulk syrup before filling, and the finished product before release. The results are on record for every batch.
A liquid section built for this range
Syrups, suspensions, drops and solutions are manufactured and filled in the oral liquid section, with a capacity of 30 million bottles a year, in 60 ml, 100 ml and 15 ml packs with measuring cups and droppers. See oral liquid manufacturing.
Proof in the packs
26 products in this range have been manufactured for marketing companies under their own brands, with our name as manufacturer on each pack.
A plant certified in 2024
WHO-GMP certified on 24 October 2024 and GMP certified under Revised Schedule M on 14 November 2024, with GLP-certified laboratories. Vendor audits by your quality team are by appointment; Chandigarh airport is 35 km away.
45 to 60 days, in time for the season
Dispatch takes 45 to 60 days from the day the artwork is finalised, for the first batch and for repeat orders. Artwork finalised in August puts the range in your depots by October.
What a respiratory, cold and cough range demands from a plant, and what we do
The technical points of this range and how the plant handles them
Solvent testing at raw material, bulk and finished product
Diethylene glycol and ethylene glycol are the contaminants that have killed children in cough syrups. The plant tests for both in-house on its Agilent gas chromatograph: every container of glycerine, propylene glycol and sorbitol before use, the bulk syrup before filling, and the finished product before release. No container is released to production and no batch is released for dispatch without a passing result on record.
Purified water
Syrups are made with purified water from the plant’s reverse osmosis system, stored in SS 316L and circulated continuously through the section, with water testing on a fixed schedule.
Taste, colour and dose in a paediatric syrup
Chlorpheniramine, dextromethorphan and terbutaline are bitter and are given to children by the spoon. Sweeteners, flavours and colours are chosen with the client and the dose is checked by assay on every batch, so that 5 ml delivers the label claim.
Preservation and stability of oral liquids
Syrups and suspensions carry a preservative system and are tested for microbial limits on every batch. Stability studies run in Thermolab chambers at the plant, and the data is available to your regulatory team on request.
Bilayer and coated tablets
Montelukast with levocetirizine, doxofylline with montelukast and acebrophylline with acetylcysteine are bilayer or film-coated tablets, compressed and coated in the tablet section. See tablet manufacturing.
Packs for the season
Syrups in 60 ml and 100 ml PET, HDPE or amber glass bottles with measuring cups, drops in 15 ml bottles with droppers, and tablets in blister packs, with cartons and leaflets to your artwork and the foil printed on the plant’s own rotogravure unit.
Ceiling prices
Salbutamol, cetirizine, chlorpheniramine, montelukast and other molecules in this range are in the National List of Essential Medicines and carry NPPA ceiling prices. We print the MRP you specify; it must stay within the ceiling for those products.
Send your product list and you will receive a written proposal from the plant at Panchkula.
Who manufactures a respiratory, cold and cough range with us
Four kinds of buyer, and what each takes from the catalogue
PCD franchise companies
A cough syrup for wet cough, one for dry cough, a cold and fever tablet, a levocetirizine, a montelukast combination and a paediatric drop, in 100 ml, 60 ml and 15 ml packs under their own brand, ready before October.
Generic marketing companies
Levocetirizine 5 mg, cetirizine 10 mg, montelukast with levocetirizine and the dextromethorphan syrups at batch sizes that hold the rate through the season.
Hospital and institutional suppliers
Salbutamol-class bronchodilators, antihistamines and expectorant syrups in the pharmacopoeial names tender lists ask for, supplied with a certificate of analysis per batch and the document set a tender file needs.
Exporters and importers
Syrups and drops in 60 ml and 100 ml packs with the leaflet and carton to the importer’s artwork, and the solvent test records with every consignment of an oral liquid.
Products in the range
Composition, dosage form and pack sizes for every product in the range.
Download the complete product list (PDF)
Cough, cold and allergy (44 products)
| Product | Form | Pack sizes |
|---|---|---|
| Ambroxol Hydrochloride and Levocetirizine Hydrochloride SyrupAmbroxol Hydrochloride IP 30mg + Levocetirizine Hydrochloride IP 5mg | Oral – SyrupEach 5ml | |
| Ambroxol Hydrochloride, Levosalbutamol Sulphate, Guaiphenesin SyrupAmbroxol Hydrochloride IP 15mg + Levosalbutamol Sulphate Eq. to Levosalbutamol IP 0.5mg + Guaiphenesin IP 50mg | Oral – Syrupper 5ml | 60ml |
| Ambroxol Hydrochloride, Terbutaline Sulphate & Guaiphenesin Oral DropsAmbroxol Hydrochloride IP 7.5mg + Terbutaline Sulphate IP 0.25mg + Guiaphenesin IP 12.5mg | Oral – Dropsper ml | |
| Ambroxol Hydrochloride, Terbutaline Sulphate and GuaiphenesinAmbroxol Hydrochloride IP 10mg + Terbutaline Sulphate IP 0.5mg + Guiaphenesin IP 25mg | Oral – Syrupper 5ml | 60ml |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin and Menthol SyrupAmbroxol Hydrochloride IP 15mg + Terbutaline Sulphate IP 1.25mg + Guiaphenesin IP 50mg + Menthol IP 2.5mg | Oral – Syrupper 5ml | 100ml |
| Bilastine Oral Solution 2.5mg/mlBilastine IP 2.5mg | Oral – Solutionper ml | |
| Bilastine Tablets 20mgBilastine 20mg | Tabletuncoated tablet | |
| Bilastine Tablets IP 20mgBilastine IP 20mg | Tabletuncoated tablet | |
| Bilastine Tablets IP 40mgBilastine IP 40mg | Tabletfilm coated tablet | |
| Cetirizine Tablets BP 10mgCetirizine BP 10mg | Tabletfilm coated tablet | |
| Cetirizine Tablets IP 10mgCetirizine Hydrochloride IP 10mg | Tabletfilm coated tablet | |
| Cyproheptadine Tablets IP 4mgCyproheptadine Hydrochloride IP 4mg | Tabletuncoated tablet | 20×10 |
| Dextromethorphan Hydrobromide and Chlorpheniramine Maleate SyrupDextromethorphan Hydrobromide IP 10mg + Chlorpheniramine Maleate IP 4mg | Oral – Syrupper 5ml | 100ml |
| Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylephrine Hydrochloride SyrupDextromethorphan Hydrobromide IP 5mg + Chlorpheniramine Maleate IP 1mg + Phenylephrine Hydrochloride IP 2.5mg | Oral – Syrupper 5ml | 60ml |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Dispersible TabletsDextromethorphan Hydrobromide IP 10mg + Phenylephrine Hydrochloride IP 5mg + Chlorpheniramine Maleate IP 2mg | Tabletuncoated dispersible tablet | 10×10, 20×10 |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate SyrupDextromethorphan Hydrobromide IP 10mg + Phenylephrine Hydrochloride IP 5mg + Chlorpheniramine Maleate IP 2mg | Oral – Syrupper 5ml | 100ml |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate SyrupDextromethorphan Hydrobromide IP 15mg + Phenylephrine Hydrochloride IP 5mg + Chlorpheniramine Maleate IP 2mg | Oral – Syrupper 5ml | 60ml, 100ml |
| Diphenhydramine Hydrochloride, Ammonium Chloride and Sodium Citrate SyrupDiphenhydramine Hydrochloride IP 14.08mg + Ammonium Chloride IP 138mg + Sodium Citrate IP 57.03mg | Oral – Syrupper 5ml | 100ml |
| Ebastine Tablets IP 10mgEbastine IP 10mg | Tabletfilm coated tablet | |
| Ebastine Tablets IP 20mgEbastine IP 20mg | Tabletfilm coated tablet | 10×10 |
| Fexofenadine Hydrochloride SuspensionFexofenadine Hydrochloride IP 30mg | Oral – Suspensionper 5ml | 100ml |
| Fexofenadine Tablets IP 120mgFexofenadine Hydrochloride IP 120mg | Tabletfilm coated tablet | |
| Fexofenadine Tablets IP 180mgFexofenadine Hydrochloride IP 180mg | Tabletfilm coated tablet | |
| Hydroxyzine Hydrochloride Oral Solution IPHydroxyzine Hydrochloride IP 10mg | Oral – Solutionper 5ml | 100ml |
| Hydroxyzine Tablets IP 10mgHydroxyzine Hydrochloride IP 10mg | Tabletfilm coated tablet | 10×15 |
| Hydroxyzine Tablets IP 25mgHydroxyzine Hydrochloride IP 25mg | Tabletfilm coated tablet | 10×15 |
| Levocetirizine Dihydrochloride SyrupLevocetirizine Dihydrochloride IP 2.5mg | Oral – Syrupper 5ml | |
| Levocetirizine Hydrochloride IP 5mgLevocetirizine Hydrochloride IP 5mg | Tabletfilm coated tablet | 10×10 |
| Levocetirizine Hydrochloride Tablets USP 5mgLevocetirizine Hydrochloride USP 5mg | Tabletfilm coated tablet | |
| Levocetirizine Hydrochloride, Ambroxol Hydrochloride, Guaiphenesin and Menthol SyrupLevocetirizine Hydrochloride IP 2.5mg + Ambroxol Hydrochloride IP 15mg + Guaiphenesin IP 50mg + Menthol IP 1mg | Oral – Syrupper 5ml | 100ml |
| Levosalbutamol, Ambroxol Hydrochloride and Guaiphenesin SyrupLevosalbutamol Sulphate Eq. to Levosalbutamol IP 1mg + Ambroxol Hydrochloride IP 30mg + Guaiphenesin IP 50mg | Oral – Syrupper 5ml | 100ml, 60ml |
| Montelukast Sodium and Bilastine TabletsMontelukast Sodium Eq. to Montelukast IP 10mg + Bilastine IP 20mg | Tabletfilm coated bilayer tablet | 10x1x10, 10×10 |
| Paracetamol and Caffeine Tablets IPParacetamol IP 650mg + Caffeine (Anhydrous) IP 50mg | Tabletuncoated tablet | |
| Paracetamol, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Oral DropsParacetamol IP 125mg + Phenylephrine Hydrochloride IP 2.5mg + Chlorpheniramine Maleate IP 1mg | Oral – Dropsper ml | 15ml |
| Phenylephrine Hydrochloride and Chlorpheniramine Maleate Oral Drops IPPhenylephrine Hydrochloride IP 2.5mg + Chlorpheniramine Maleate IP 1mg | Oral – Dropsper ml | |
| Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup IPPhenylephrine Hydrochloride IP 5mg + Chlorpheniramine Maleate IP 2mg | Oral – Syrupper 5ml | |
| Promethazine Syrup IP 5mgPromethazine Hydrochloride IP 5mg | Oral – Syrupper 5ml | |
| Terbutaline Sulphate, Ambroxol Hydrochloride and Guaiphenesin SyrupTerbutaline Sulphate IP 0.25mg + Ambroxol Hydrochloride IP 7.5mg + Guaiphenesin IP 12.5mg | Oral – Syrupper ml | 15ml |
| Terbutaline Sulphate, Ambroxol Hydrochloride and Guaiphenesin TabletsTerbutaline Sulphate IP 2.5mg + Ambroxol Hydrochloride IP 30mg + Guaiphenesin IP 100mg | Tabletuncoated tablet | |
| Terbutaline Sulphate, Ambroxol Hydrochloride, Guaiphenesin and Menthol SyrupTerbutaline Sulphate IP 1.25mg + Ambroxol Hydrochloride IP 15mg + Guaiphenesin IP 50mg + Menthol IP 0.5mg | Oral – Syrupper 5ml | 100ml |
| Terbutaline Sulphate, Ambroxol Hydrochloride, Guaiphenesin and Menthol SyrupTerbutaline Sulphate IP 1.5mg + Ambroxol Hydrochloride IP 30mg + Guaiphenesin IP 100mg + Menthol IP 2.5mg | Oral – SyrupEach 5ml | |
| Terbutaline Sulphate, Bromhexine Hydrochloride and Guaiphenesin SyrupTerbutaline Sulphate IP 1.25mg + Bromhexine Hydrochloride IP 4mg + Guaiphenesin IP 50mg | Oral – Syrupper 5ml | |
| Terbutaline Sulphate, Bromhexine Hydrochloride and Guaiphenesin TabletsTerbutaline Sulphate IP 2.5mg + Bromhexine Hydrochloride IP 8mg + Guaiphenesin IP 100mg | Tabletuncoated tablet | |
| Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesin and Menthol SyrupTerbutaline Sulphate IP 1.25mg + Bromhexine Hydrochloride IP 2mg + Guaiphenesin IP 50mg + Menthol IP 0.5mg | Oral – Syrupper 5ml | 100ml |
Asthma and bronchodilators (17 products)
| Product | Form | Pack sizes |
|---|---|---|
| Acebrophylline and N-Acetylcysteine TabletsAcebrophylline 100mg + N-Acetylcysteine BP 600mg | Tabletfilm coated bilayer tablet | 10×10 |
| Acebrophylline Capsules 100mgAcebrophylline 100mg | Capsulehard gelatin capsule | 10×10 |
| Acebrophylline Sustained Release Tablets 200mgAcebrophylline (as sustained release form) 200mg | Tabletfilm coated tablet | 10×10 |
| Acebrophylline, Guaiphenesin and Terbutaline Sulphate SyrupAcebrophylline 50mg + Guaiphenesin IP 50mg + Terbutaline Sulphate IP 1.25mg | Oral – Syrupper 5ml | 100ml |
| Desloratadine and Montelukast TabletsDesloratadine BP 5mg + Montelukast Sodium Eq. to Montelukast IP 10mg | Tabletfilm coated tablet | 10×10 |
| Desloratadine Tablets 5mgDesloratadine BP 5mg | Tabletfilm coated tablet | 10×10 |
| Desloratadine Tablets USP 5mgDesloratadine USP 5mg | Tabletfilm coated tablet | |
| Doxofylline (SR) and Montelukast TabletsDoxofylline (as sustained release form) IP 400mg + Montelukast Sodium Eq. to Montelukast IP 10mg | Tabletuncoated tablet | 10X10 |
| Doxofylline Tablets IP 400mgDoxofylline IP 400mg | Tabletuncoated tablet | |
| Montelukast and Fexofenadine Hydrochloride SuspensionMontelukast Sodium Eq. to Montelukast IP 4mg + Fexofenadine Hydrochloride IP 30mg | Oral – Suspensionper 5ml | 60ml |
| Montelukast and Fexofenadine Hydrochloride TabletsMontelukast Sodium Eq. to Montelukast IP 10mg + Fexofenadine Hydrochloride IP 120mg | Tabletfilm coated tablet | 10×10 |
| Montelukast and Levocetirizine SyrupMontelukast Sodium Eq. to Montelukast IP 4mg + Levocetirizine Dihydrochloride IP 2.5mg | Oral – Syrupper 5ml | 60ml, 30ml |
| Montelukast and Levocetirizine Tablets IPMontelukast Sodium Eq. to Montelukast IP 10mg + Levocetirizine Dihydrochloride IP 5mg | Tabletfilm coated tablet | 10×10, 10×15, 20×10 |
| Montelukast Dispersible and Levocetirizine Dihydrochloride TabletsMontelukast Sodium Eq. to Montelukast IP 5mg + Levocetirizine Dihydrochloride IP 2.5mg | Tabletdispersible tablet | |
| Montelukast Sodium and Levocetirizine Dihydrochloride Dispersible TabletsMontelukast Sodium Eq. to Montelukast IP 4mg + Levocetirizine Dihydrochloride IP 2.5mg | Tabletuncoated dispersible tablet | 10×10 |
| Montelukast Sodium and Levocetirizine Dihydrochloride Tablets IPMontelukast Sodium Eq. to Montelukast IP 10mg + Levocetirizine Dihydrochloride IP 5mg | Tabletuncoated bilayer tablet | 10X10 |
| Montelukast Sodium, Levocetirizine Dihydrochloride and Ambroxol Hydrochloride (SR) TabletsMontelukast Sodium Eq. to Montelukast IP 10mg + Levocetirizine Dihydrochloride IP 5mg + Ambroxol Hydrochloride (As sustained release form) IP 75mg | Tabletuncoated bilayer tablet | 10×10 |
Rate, batch, lead time and documents
The terms every proposal states
Rate
The rate is quoted in writing, product by product, against your pack sizes and annual quantity. The plant is outside the hill-state budgetary-support scheme, so the rate you receive now is the rate after March 2027.
Minimum quantity
One batch per product. The batch size for each product is stated in the proposal.
Lead time
Dispatch takes 45 to 60 days from the day the artwork is finalised, for the first batch and for repeat orders.
Payment
An advance on the first order, and terms as mutually agreed after that.
Dispatch
To your depots in any state by road, with freight to your account.
Documents
A certificate of analysis with every batch, copies of the licences and certificates, the Site Master File for vendor qualification, stability data on request, and a quality agreement after order confirmation.
Compliance notes for this range
Prices, combinations and labelling
Fixed-dose combinations
Combinations are manufactured only where the combination is approved. The cough and cold combinations prohibited by the Ministry of Health, including the fourteen notified on 2 June 2023, are not manufactured.
Labelling
The products in this range are labelled with the generic name in the prominence required by Rule 96 and the manufacturer’s name, licence number and batch details on every pack. Chlorpheniramine and phenylephrine drops carry the statement that the combination is not to be used in children below four years, as directed by the Drugs Controller General of India in December 2023.
Release
Every batch is tested in the GLP-certified laboratory, including the diethylene glycol and ethylene glycol tests on the raw material, the bulk and the finished product, and released with a certificate of analysis that travels with the consignment.
Why respiratory, cold and cough is the range to build
The market, the season and the manufacturer question, with sources
A 19,000 crore therapy growing above the market
Respiratory medicines were worth 19,043 crore rupees in the year to January 2026, 7.9 per cent of the Indian pharmaceutical market, and grew 10.3 per cent against 8.0 per cent for the market as a whole. Source: Pharmarack Technologies, industry report for January 2026.
The season doubles the sales
Respiratory sales rose from 989 crore rupees in June 2024 to 1,638 crore rupees in November 2024, a 66 per cent rise in five months, with cough and cold products up 11.3 per cent in November alone as the monsoon, the cold and the air quality set in. A range that is on the shelf by October sells through the whole season. Source: Pharmarack figures reported in Business Standard, 12 December 2024.
Every doctor and every chemist
Cough, cold and allergy products are prescribed by general practitioners, paediatricians, physicians and chest specialists, and the syrups sell over the counter as well. A marketing company with a pain or cardiac range adds respiratory products to the same doctors and chemists without adding a single visit.
The 2025 syrup crisis made the manufacturer the first question
In October 2025, cough syrups contaminated with diethylene glycol from a manufacturer in Tamil Nadu caused the deaths of at least 24 children in Madhya Pradesh and Rajasthan; the manufacturer’s licences were cancelled, the World Health Organization issued a product alert on 13 October 2025, and the Health Ministry advised that cough and cold medicines are not to be given to children below two years. A marketing company that sells a syrup under its own name carries the risk of its manufacturer, and buyers now ask where the syrup is made and how it is tested for diethylene glycol before they ask the rate. Sources: WHO Medical Product Alert 5/2025; Ministry of Health advisory, 4 October 2025.
The approved combinations are the range
Between 2016 and 2024 the Ministry of Health prohibited more than a hundred cough and cold combinations, including fourteen on 2 June 2023. The combinations that remain approved, terbutaline with bromhexine and guaiphenesin, levosalbutamol with ambroxol and guaiphenesin, dextromethorphan with chlorpheniramine and phenylephrine, montelukast with levocetirizine, and the single antihistamines, are what the market now runs on, and all of them are in this catalogue. Source: CDSCO list of drugs prohibited under Section 26A.
Factory tour video
Seven minutes inside the WHO-GMP plant at Dabkori, Panchkula, covering the manufacturing sections, packing lines and laboratories.
Questions marketing companies ask
Answered from the plant
Which respiratory, cold and cough products can you manufacture under our brand?
All 61 products in the catalogue. If you need a composition that is not on the list, send it with the strength and pack; a product not yet on the licence needs the state authority’s endorsement before the first batch, which adds a few weeks.
How do you make sure a syrup is free of diethylene glycol?
By testing three times, in-house, on the plant’s Agilent gas chromatograph: every container of glycerine, propylene glycol and sorbitol before it is used, the bulk syrup before filling, and the finished product before release. The results support the certificate of analysis, and the test records are available to your quality team.
Can you make paediatric drops and syrups with our flavour?
Yes. Drops in 15 ml bottles with droppers and syrups in 60 ml and 100 ml bottles are made in the oral liquid section, and the flavour, colour and sweetener are settled with you before the first batch.
When should we finalise artwork for the winter season?
By August. Dispatch takes 45 to 60 days from the day the artwork is finalised, so August artwork puts the range in your depots by October, when respiratory sales begin to rise.
What is the minimum quantity for a respiratory range?
One batch per product. The batch size depends on the product and pack, and the written proposal states it against each product you ask for.
Can you match the formulation of a brand we already sell?
Send the reference product and its pack. For a product already on our licence the first batch follows the standard 45 to 60 day timeline; where the flavour system or excipients differ from ours, the formulation team assesses the change before quoting, and any product not yet on the licence needs the state endorsement first.
Do you supply the documents our regulatory team needs?
Yes. Copies of the manufacturing licence and WHO-GMP certificate, the Site Master File, a certificate of analysis with every batch, the solvent test records, and stability data on request. A quality agreement is signed after order confirmation.
Send your product list today
Send us your products and strengths, pack sizes, annual quantity and artwork status. You will receive a written proposal covering rate, batch size, pack format, capacity, payment terms, lead time and documents.
info.vh@vibcare.co.in · +91 85660 76607 · Khasra 6/2/2, Kot Road, Village Dabkori, Panchkula, Haryana 134103 · Download brochure
